Expert Interview
A look at the data from the SURMOUNT-5 phase 3b head-to-head weight loss trial of Zepbound (tirzepatide) compared to Wegovy (semaglutide).
Ticker(s): LLY, NVOInstitution: UT Southwestern Medical Center
- Board-certified endocrinologist, Professor of medicine, and Director of the Diabetes Clinic at UT Southwestern Medical Center and Parkland Hospital.
- Currently manages 200 patients with Type 1 Diabetes and 10 patients that use the Omnipod System.
- Clinical research interests include diabetes management, prevention, and novel treatments while serving as the chair of Biomedical research.
Roughly how many patients do you treat with weight loss medication?
Added By: sara_adminDo you prescribed one of these more than the other and why? Do you or your patients prefer one of the other?
Added By: sara_adminCan you share your professional background and details about your clinical practice, including how many patients you treat for obesity?
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
